Fact Based List:
Deborah L. Feinstein: Four design features of ACOs that raise red flags for antitrust agencies
Submitted by Charlene Ice on Fri, 07/25/2014 - 16:30
- preventing payers from steering patients to certain providers
- tying sales of the ACO’s services to the private payer’s purchase of other services from providers outside the ACO
- requiring exclusivity that discourages providers from contracting with payers outside the ACO
- restricting a payer’s ability to make available to enrollees information on cost, quality, efficiency, and performance
Notes: Deborah L. Feinstein is the Director of the Federal Trade Commission's Bureau of Competition. This list is from her presentation at the Fifth National ACO Summit.
Source: "Antitrust Enforcement in Health Care: Proscription, not Prescription," Fifth National Accountable Care Organization Summit – Washington, DC
Source URL: http://www.ftc.gov/system/files/documents/public_statements/...
List Ratings: |
Lists You Might Also Be Interested In
- Six Things to Know from Oliver Wyman's 2015 ACO Report
- 6 Things to Know about 2014 MSSP ACO Performance
- 4 Statistics on Healthcare Administrators' Feelings About ACOs
- Strive Health: 7 Things to know about End-Stage Renal Disease (ESRD) in MSSP ACOs
- The 32 organizations participating in the Medicare Pioneer ACO Model
Login or register to post comments